These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8623215)

  • 1. Interaction between FK 506 and diltiazem in an animal model.
    Regazzi MB; Iacona I; Alessiani M; Spada M; Vaccarisi S; Villani P; Molinaro M
    Transplant Proc; 1996 Apr; 28(2):1017-8. PubMed ID: 8623215
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic characteristics of two types of liposomal FK 506.
    Yagura K; Nakajima Y; Ko S; Kanehiro H; Nakano H
    Transplant Proc; 1996 Jun; 28(3):1390-1. PubMed ID: 8658708
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tacrolimus hydrate (tacrolimus)].
    Matsuda J
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():465-8. PubMed ID: 15658364
    [No Abstract]   [Full Text] [Related]  

  • 4. Diltiazem does not always increase blood cyclosporin concentration.
    Jones TE; Morris RG
    Br J Clin Pharmacol; 1996 Nov; 42(5):642-4. PubMed ID: 8951199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of FK 506 in a swine model of liver-small bowel allotransplantation.
    Reggiani P; Gatti S; Rossi G; Orsenigo R; Maggi U; Leoni L; Ceccherelli F; Colledan M; Gridelli B; Piazzini-Albani A; Galmarini M; Andreani P; Bardella MT; Langer M; Doglia M; Fassati LR; Galmarini D
    Transplant Proc; 1996 Oct; 28(5):2587-8. PubMed ID: 8907965
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid and simultaneous determination of tacrolimus (FK506) and diltiazem in human whole blood by liquid chromatography-tandem mass spectrometry: application to a clinical drug-drug interaction study.
    Li JL; Wang XD; Wang CX; Fu Q; Liu LS; Huang M; Zhou SF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 May; 867(1):111-8. PubMed ID: 18417431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between tacrolimus and omeprazole in a pediatric liver transplant recipient.
    Moreau C; Debray D; Loriot MA; Taburet AM; Furlan V
    Transplantation; 2006 Feb; 81(3):487-8. PubMed ID: 16477241
    [No Abstract]   [Full Text] [Related]  

  • 8. Diltiazem increases tacrolimus concentrations.
    Hebert MF; Lam AY
    Ann Pharmacother; 1999 Jun; 33(6):680-2. PubMed ID: 10410178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of diltiazem on tacrolimus pharmacokinetics in tacrolimus-induced nephrotoxic rats.
    Tada H; Yanagiwara S; Ito K; Suzuki T
    Pharmacol Toxicol; 1999 Jun; 84(6):241-6. PubMed ID: 10401724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus.
    Alessiani M; Regazzi M; Abbiati F; Ferrari P; Molinaro M; Iacona I; Klersy C; Viezzoli A; Fayer F; Pileggi A; Zitelli E; Burroni B; Scandone M; Dionigi P; Zonta A
    Transplant Proc; 2000 Sep; 32(6):1214-5. PubMed ID: 10995915
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
    Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
    Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
    [No Abstract]   [Full Text] [Related]  

  • 12. Liposomal tacrolimus and intestinal drug concentration.
    Dutta S; Mezei M; Lee TD; McAlister VC
    Transplant Proc; 1998 Sep; 30(6):2651-2. PubMed ID: 9745533
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus clearance is age-dependent within the pediatric population.
    Przepiorka D; Blamble D; Hilsenbeck S; Danielson M; Krance R; Chan KW
    Bone Marrow Transplant; 2000 Sep; 26(6):601-5. PubMed ID: 11041564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
    Pea F; Tavio M; Pavan F; Londero A; Bresadola V; Adani GL; Furlanut M; Viale P
    Antivir Ther; 2008; 13(5):739-42. PubMed ID: 18771060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients.
    Staatz CE; Willis C; Taylor PJ; Tett SE
    Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Blough DK; Townsend RW; Allison M; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Sep; 45(9):1018-24. PubMed ID: 16100295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trough levels of tacrolimus.
    Stolk LM; Van Duijnhoven EM; Christiaans MH; van Hooff JP
    Ther Drug Monit; 2002 Aug; 24(4):573; author reply 573-4. PubMed ID: 12142646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tacrolimus (FK 506): immunosuppressive alternative to solid organ transplant (Part 1)].
    Díaz M; Azanza JR; Sádaba B; López de Ocáriz A
    Rev Med Univ Navarra; 1995; 39(1):28-40. PubMed ID: 14735715
    [No Abstract]   [Full Text] [Related]  

  • 20. Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors.
    Vallazza-Deschamps G; Cia D; Gong J; Jellali A; Duboc A; Forster V; Sahel JA; Tessier LH; Picaud S
    Eur J Neurosci; 2005 Sep; 22(5):1013-22. PubMed ID: 16176343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.